Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application (ANDA) for Semaglutide Injection, marking a ...
People who have had a heart attack, stroke, or serious circulation problem in their legs, and who also carry excess weight, can now be offered a weekly injection to help protect them from a further ...
Discover more about Novo Nordisk’s launch of the company’s now highest dosage of injectable semaglutide, following last ...
More than a million patients who have had a heart attack or stroke and are overweight will now be eligible for weight loss ...
Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...
NICE has recommended Wegovy® (semaglutide injection) 2.4 mg as the first GLP-1 RA to reduce the risk of major adverse ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...
Emcure slashes semaglutide injection price by 55%, prompting potential moves from Abbott to follow suit in India.
Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of ...
Why semaglutide injection pens cost more than vials: OneSource CEO explains manufacturing complexity
OneSource Specialty Pharma details why semaglutide injection pens cost more than vials, highlighting complex sterile manufacturing and rising global GLP 1 demand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results